The global non-invasive intracranial pressure monitoring devices market size is anticipated to reach USD 478.1 million by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.2% from 2025 to 2030. Increasing incidences of neurological diseases, coupled with a subsequent rise in the number of surgical procedures to treat associated conditions, are driving the market.
Non-invasive intracranial pressure monitoring devices are used to measure the pressure within the skull caused by trauma or medical conditions, such as intracranial hypertension, hydrocephalus, subarachnoid hemorrhages, inflammatory diseases, and cerebrospinal space diseases. These devices help in monitoring the pressure, as increased Intracranial Pressure (ICP) can result in serious or life-threatening medical problems.
Moreover, the high incidence rate of traumatic brain injuries due to road accidents and sports incidents is anticipated to boost the demand for non-invasive intracranial pressure monitoring devices. For instance, globally, in 2020 alone, around 11 million individuals are estimated to be affected by Traumatic Brain Injuries (TBIs).
Additionally, key players are adopting various strategies, such as M&A, partnerships, and product launches, to strengthen their foothold in the market. For instance, in November 2019, Raumedic AG introduced the ICP monitoring device for home use, which is intended for the diagnosis of people who suffer from hydrocephalus.
Request a free sample copy or view report summary: Non-invasive Intracranial Pressure Monitoring Devices Market Report
On the basis of type, the MRI/CT scan segment dominated the overall market with a share of 28.4% in 2024. These are robust imaging tools that can detect early signs of injuries, such as microhemorrhage, contusion, and hydrocephalus, due to their higher sensitivity unlike others
Based on the application, The traumatic brain injury segment dominated the non-invasive intracranial pressure monitoring devices industry with the largest revenue share in 2024 owing to the increasing prevalence of TBI and high demand for ICP monitoring devices in trauma care centers
North America dominated the market with the largest revenue share of 45.1% in 2024 owing to the high incidence of trauma cases and easy availability of technologically advanced healthcare infrastructure in the region
Grand View Research has segmented the global non-invasive intracranial pressure monitoring devices market report based on type, application, and region
Non-invasive Intracranial Pressure Monitoring Devices Type Outlook (Revenue, USD Million; 2018 - 2030)
Transcranial Doppler Ultrasonography
Tympanic Membrane Displacement (TMD)
Optic Nerve Sheath Diameter
MRI/CT
Fundoscopy (papilledema)
Non-invasive Intracranial Pressure Monitoring Devices Application Outlook (Revenue, USD Million; 2018 - 2030)
Traumatic Brain Injury
Intracerebral Hemorrhage
Meningitis
Subarachnoid Hemorrhage
Others
Non-invasive Intracranial Pressure Monitoring Devices Regional Outlook (Revenue, USD Million; 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Non-invasive Intracranial Pressure Monitoring Devices Market
Medtronic
Integra LifeSciences Corporation
Spiegelberg GmbH & Co. KG
RAUMEDIC AG
Vittamed
Gaeltec Devices Limited.
HeadSense Medical
NeuroDx Development
Sophysa
"The quality of research they have done for us has been excellent..."